Searched for
DIABETES CRISIS INDIA
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...
- Dietary balance remains missing as India continues to gorge on cerealsMany Indians consume too many grains and not enough proteins, vegetables and fruits. This imbalance affects health, contributing to malnutr...
- Kerala’s healthcare gold rush: How private equity is reshaping hospitals and raising fears over costsPrivate equity funds are pouring hundreds of millions of dollars into Kerala’s healthcare sector, reshaping a system long dominated by inde...
- NPS Swasthya: A cushion, not fill-in, for health coverCan the NPS Swasthya scheme be an effective substitute for a comprehensive health insurance plan that covers hospitalisation and related ex...
- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- Dubai woman blames 'Iran vs US vs Israel' family war at home for blood sugar spike. Diabetics doctor advises her to act like India - 'Get things done without being involved in any conflicts'A Dubai doctor shared a patient's unique explanation for rising blood sugar. The patient described her home as a war zone with family membe...
- Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas TambeBiocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...
- Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahead?Pharma stocks rose up to 4% as Novo Nordisk’s semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong gr...
- We need to quickly get OzempickyAffordable semaglutide generics are coming to India. This drug helps with diabetes and weight loss. Millions need it for health issues. How...
- Urban India faces metabolic health crisis as 73 million are overweight or obeseIn India's vibrant urban landscape, obesity and diabetes are becoming formidable adversaries. A new analysis highlights that while countles...
- How sedentary work culture is fuelling India’s early diabetes crisisIndia faces a growing diabetes crisis, with over 100 million adults affected, exacerbated by sedentary work culture. Prolonged sitting and ...
- How a triple threat of diseases is pushing India toward a health emergencyA panel of Padma awardee doctors warns that India faces a looming health emergency due to the rapid increase in non-communicable diseases l...
- Zerodha's Nithin Kamath shares simple tips to prevent India’s scariest health problem affecting 21 cr peopleZerodha CEO Nithin Kamath has raised an urgent warning about India’s rising soft drink consumption and its link to the country’s escalating...
- Zerodha CEO Nithin Kamath spots worrying trend from a recent earnings callZerodha CEO Nithin Kamath raised concern over surging soft drink consumption in India, citing Coca-Cola's strong Q1 growth and linking it t...
- Cardiovascular diseases, diabetes major contributors to health challenges in military: Rajnath SinghDefense Minister Rajnath Singh addressed the Cardiological Society of India, highlighting the high prevalence of cardiovascular diseases an...
- 'A time bomb is ticking': Zerodha's Nithin Kamath sounds alarm for young Indian men and womenZerodha CEO Nithin Kamath raises concern about the increasing number of diabetes cases in India. He highlights the alarming statistics and ...
- People living with diabetes to double by 2050: The LancetResearchers say diabetes is growing exponentially in prevalence outpacing most diseases globally. Structural racism and geographic inequity...
- Celebrating unsung heroes at The Economic Times - Doctors Day Conclave
- Lifestyle diseases could cause huge losses to IndiaThe economic loss in India, which was $8.7 billion in 2005, is projected to rise to $54 billion in 2015, according to a WHO report. Keep go...
Load More
